Twist Bioscience Corporation (TWST) earnings
TWST earnings moved a median of -1.28% by the close. Quarterly and annual TWST reports and results, each read against the price at its own news timestamp. Back to the TWST overview →
16 measured TWST earnings events.
Where these TWST earnings landedvs 16 measured TWST earnings reactions
| Middle 50% of TWST earnings reactions | -4.46% to +0.16% |
|---|---|
| Median reaction (to close) | -1.28% |
| Measured reactions | 16 |
Point-in-time · zero look-ahead
Half of the 16 TWST earnings events with a measured close landed between -4.46% and +0.16%; 25% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Twist Bioscience Corp For: Jun 30 | SEC filing · Form 10-Q | -4.16% | -6.70% | |
| Form 10-Q Twist Bioscience Corp For: Mar 31 | SEC filing · Form 10-Q | +1.40% | -2.78% | |
| Form 10-Q/A Twist Bioscience Corp For: Dec 31 | SEC filing · Form 10-Q | +0.13% | -1.16% | |
| Form 10-Q Twist Bioscience Corp For: Dec 31 | SEC filing · Form 10-Q | -2.67% | -0.64% | |
| Form 10-K Twist Bioscience Corp For: Sep 30 | SEC filing · Form 10-K | -2.81% | -1.05% | |
| Form 10-Q Twist Bioscience Corp For: Jun 30 | SEC filing · Form 10-Q | -3.21% | -11.25% | |
| Form 10-Q Twist Bioscience Corp For: Mar 31 | SEC filing · Form 10-Q | -1.44% | -7.25% | |
| Form 10-Q Twist Bioscience Corp For: Dec 31 | SEC filing · Form 10-Q | +0.07% | -2.57% | |
| Form 10-K Twist Bioscience Corp For: Sep 30 | SEC filing · Form 10-K | -1.44% | -0.96% | |
| Form 10-Q Twist Bioscience Corp For: Jun 30 | SEC filing · Form 10-Q | -3.62% | +16.26% | |
| Twist Bioscience Reports Fiscal Third Quarter 2024 Financial Results | Press release | -1.61% | -10.48% | |
| Form 10-Q Twist Bioscience Corp For: Mar 31 | SEC filing · Form 10-Q | -2.93% | +7.65% | |
| Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results | Press release | -2.93% | +7.65% | |
| Form 10-Q Twist Bioscience Corp For: Dec 31 | SEC filing · Form 10-Q | -0.65% | +2.56% | |
| Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results | Press release | -4.29% | -3.71% | |
| Form 10-K Twist Bioscience Corp For: Sep 30 | SEC filing · Form 10-K | -0.46% | -1.41% |
Keep exploring
More TWST: analyst actions → · SEC filings → · TWST overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| PORTOLA PHARMACEUTICALS (PTLA) | 915 | -0.04% | 48% |
| Illumina, Inc. (ILMN) | 914 | +0.02% | 51% |
| Boston Scientific Corporation (BSX) | 912 | +0.07% | 54% |
| Concert Pharmaceuticals, Inc. (CNCE) | 911 | 0.00% | 48% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.